Urolithin A protects against acetaminophen-induced liver injury in mice via sustained activation of Nrf2

作者：Gao, Zhimin; Yi, Wei; Tang, Junyuan; Sun, Yuling; Huang, Jianrong; Lan, Tian; Dai, Xiaoyan; Xu, Suowen; Jin, Zheng-Gen; Wu, Xiaoqian^*

来源：International Journal of Biological Sciences, 2022, 18(5): 2146-2162.

DOI：10.7150/ijbs.69116

• Acute liver injury
• Acetaminophen
• Mitophagy
• Nrf2
• Urolithin A

Acetaminophen overdose is a leading cause of acute live failure worldwide. N-acetylcysteine (NAC), as the only antidote, is limited due to its narrow therapeutic time Here we demonstrated that Urolithin A (UA), a metabolite of ellagitannin natural products in the gastrointestinal flora, protected against acetaminophen-induced liver injury (AILI) and is superior to NAC in terms of dosage and therapeutical time Transcriptomics assay revealed that UA promotes mitophagy and activated Nrf2/ARE signaling in the liver. Consistent with that, mitophagy and Nrf2/ARE signaling were activated, with less oxidative stress in UA-treated liver. Subsequently, molecular docking and dynamics simulation study revealed a binding mode between UA and Nrf-2/Keapl including the hydrogen-bonding network among oxygen atoms in UA with the Nrf-2/Keapl residues Arg 415, Ser 508 and Ser 602, which in turn trigger Nrf2 nuclear translocation, subsequently leading to activation of Nrf-2 target genes (HO-1, NQO1). Of note, mitophagy inhibition failed to prevent the protection of UA against AILI, which instead was compromised with Nrf2 gene silencing both in vivo and in vitro. Collectively, our data indicate that UA alleviated acetaminophen-induced oxidative stress and hepatic necrosis via activating Nrf2/ARE signaling pathway, highlighting a therapeutical potential of UA for AILI.

• 单位
  广州医学院; 1; 广东药学院; 5